Experimental nasal flu vaccine tested in children and teens
by Press Release from Outbreak News Today on (#3Z081)
An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit (VTEU) site at Saint Louis University, Missouri. The VTEU is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part ["]
The post Experimental nasal flu vaccine tested in children and teens appeared first on Outbreak News Today.